Equillium, Inc.

EQ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Apr 15, 2026 DEFA14A
DEF 14A Apr 15, 2026 DEF 14A
CORRESP Apr 14, 2026
UPLOAD Apr 13, 2026
S-3 Apr 7, 2026 S-3
PRE 14A Mar 30, 2026 PRE 14A
EFFECT Mar 25, 2026
S-8 Mar 25, 2026 S-8
10-K Mar 25, 2026 10-K
8-K Mar 25, 2026 8-K
CORRESP Mar 23, 2026
SCHEDULE 13G Mar 20, 2026
4 Mar 16, 2026
144 Mar 13, 2026
8-K Mar 13, 2026 8-K
4/A Mar 11, 2026
4 Mar 11, 2026
144 Mar 9, 2026
4 Feb 23, 2026
144 Feb 19, 2026
SCHEDULE 13G/A Feb 6, 2026
4 Jan 9, 2026
4 Jan 9, 2026
4 Jan 9, 2026
4 Jan 9, 2026
← Newer Page 2 of 19 · 463 filings Older →